Correction to: Two-hour post-challenge glucose is a better predictor of adverse outcome after myocardial infarction than fasting or admission glucose in patients without diabetes.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Works matching IS 09405429 AND DT 2018 AND VI 55 AND IP 5
Results: 13
1
2
Work-loss years among people diagnosed with diabetes: a reappraisal from a life course perspective.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 485, doi. 10.1007/s00592-018-1119-x
- By:
- Publication type:
- Article
3
Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: findings from the RADIEL study follow-up.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 493, doi. 10.1007/s00592-018-1118-y
- By:
- Publication type:
- Article
4
SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 503, doi. 10.1007/s00592-018-1116-0
- By:
- Publication type:
- Article
5
Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 429, doi. 10.1007/s00592-018-1107-1
- By:
- Publication type:
- Article
6
Two-hour post-challenge glucose is a better predictor of adverse outcome after myocardial infarction than fasting or admission glucose in patients without diabetes.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 449, doi. 10.1007/s00592-018-1114-2
- By:
- Publication type:
- Article
7
Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus<sup>®</sup>) and Lantus<sup>®</sup> in healthy subjects: a double-blind, randomized clamp study.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 461, doi. 10.1007/s00592-018-1113-3
- By:
- Publication type:
- Article
8
The risk of type 2 diabetes mellitus according to the categories of body mass index: the Korean Genome and Epidemiology Study (KoGES).
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 479, doi. 10.1007/s00592-018-1112-4
- By:
- Publication type:
- Article
9
Identification of megakaryocytes as a target of advanced glycation end products in diabetic complications in bone marrow.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 419, doi. 10.1007/s00592-018-1109-z
- By:
- Publication type:
- Article
10
Optical coherence tomography angiography discerns preclinical diabetic retinopathy in eyes of patients with type 2 diabetes without clinical diabetic retinopathy.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 469, doi. 10.1007/s00592-018-1115-1
- By:
- Publication type:
- Article
11
Association between IgH enhancer hs1.2 and type 1 diabetes.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 443, doi. 10.1007/s00592-018-1103-5
- By:
- Publication type:
- Article
12
Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 405, doi. 10.1007/s00592-017-1086-7
- By:
- Publication type:
- Article
13
Soluble programmed death-1 ligand 1(sPD-L1) is significantly reduced in the serum of type 1 diabetes patients.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 515, doi. 10.1007/s00592-017-1081-z
- By:
- Publication type:
- Article